AlphaYou
Overview
Smart money at a glance
Filings to Sep 23, 2026Net buying: insiders sold $0 and bought $2K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$2K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
Key stats
Fundamentals Sep 23- 52-wk high
- $7.35
- 52-wk low
- $2.07
- Prev close
- $4.94
- Mkt cap
- $15.6M
- Beta
- -1.03
- P/S
- 9.1x
- P/B
- 3.6x
- Profit margin
- +0.0%
- Op margin
- -616.0%
- ROE
- -356.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ICU filings
Are insiders buying or selling SeaStar Medical Holding Corporation (ICU) stock?
Net buying: insiders sold $0 and bought $2K of ICU stock on the open market in the 90 days to Sep 23, 2026, according to SEC Form 4 filings. The largest was Messinger, Michael (Chief Financial Officer), who bought $2K. The latest filing was on Aug 19, 2026.
Which members of Congress have traded ICU recently?
None. No member of Congress disclosed a ICU trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ICU smart-money data?
This summary uses filings available on Sep 23, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position and insiders have been net buying.
What insiders are doing
Buys (1)
- MM
Messinger Michael
$2K
bought
How top traders are positioned
No tracked top-trader positions in ICU right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
-$0.91 expected
Reports Nov 12, 2026, in 50 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $16M
Valuation
- P/S9.08
- P/B3.63
Quality
- Operating margin-616.0%
- ROE-356.9%
- ROA-102.7%
Growth
- Beta-1.03
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.